Gulani Mahek, Arte Tanisha, Ferguson Amarae, Pasupuleti Dedeepya, Adediran Emmanuel, Harsoda Yash, Nicolas McCommon Andrew, Gala Rikhav, D'Souza Martin J
Vaccine Nanotechnology Laboratory, College of Pharmacy, Center for Drug Delivery Research, Mercer University, Atlanta, GA 30341, USA.
Department of Pharmaceutical Sciences, Larkin College of Pharmacy, 18301 North Miami Ave., Miami, FL 33169, USA.
Vaccines (Basel). 2025 Sep 16;13(9):978. doi: 10.3390/vaccines13090978.
Vaccines remain one of the most powerful tools in modern medicine, having revolutionized public health by preventing millions of deaths and controlling the spread of infectious diseases worldwide. However, conventional needle-based vaccines face several limitations, including pain and discomfort, the need for cold-chain infrastructure, reliance on trained healthcare personnel, risk of cross-contamination, and limited accessibility in low-resource settings. These challenges have spurred the development of non-invasive vaccination approaches that promise safer, more accessible, and patient-friendly immunization. Non-invasive immunizations not only eliminate the need for needles but may also enhance compliance and enable mucosal immune responses. To harness the full potential of these innovative delivery routes, a comprehensive understanding of their formulation strategies and mechanism of action is essential. This review aims to comprehensively discuss recent advancements in oral, intranasal, microneedle, buccal, sublingual, and vaginal vaccinations and highlight their underlying immunological mechanisms, formulation strategies in preclinical studies, examples of marketed products, and ongoing clinical trials.
疫苗仍然是现代医学中最强大的工具之一,通过预防数百万人死亡并控制全球传染病的传播,彻底改变了公共卫生状况。然而,传统的基于针头的疫苗面临着几个局限性,包括疼痛和不适、对冷链基础设施的需求、对训练有素的医护人员的依赖、交叉污染风险以及在资源匮乏地区的可及性有限。这些挑战推动了非侵入性疫苗接种方法的发展,这些方法有望实现更安全、更易获取且对患者更友好的免疫接种。非侵入性免疫接种不仅消除了对针头的需求,还可能提高依从性并引发黏膜免疫反应。为了充分发挥这些创新给药途径的潜力,全面了解其制剂策略和作用机制至关重要。本综述旨在全面讨论口服、鼻内、微针、颊部、舌下和阴道疫苗接种的最新进展,并突出其潜在的免疫机制、临床前研究中的制剂策略、上市产品实例以及正在进行的临床试验。